-
1Academic Journal
Συγγραφείς: S. N. Khostelidi, V. A. Zaytsev, S. A. Vartanyan, N. A. Nikitin, G. N. Evtukh, M. N. Gilalov, G. V. Portnov, A. A. Zubareva, I. B. Baranova, T. S. Bogomolova, Yu. L. Avdeenko, O. V. Shadrivova, E. A. Desyatik, E. V. Shagdileeva, Yu. V. Borzova, Yu. A. Krivolapov, N. V. Vasilyeva, N. N. Klimko, С. Н. Хостелиди, В. А. Зайцев, С. А. Вартанян, Н. А. Никитин, Г. Н. Евтух, М. Н. Гилялов, Г. В. Портнов, А. А. Зубарева, И. Б. Баранова, Т. С. Богомолова, Ю. Л. Авдеенко, О. В. Шадривова, Е. А. Десятик, Е. В. Шагдилеева, Ю. В. Борзова, Ю. А. Криволапов, Н. В. Васильева, Н. Н. Климко
Πηγή: Journal Infectology; Том 14, № 2 (2022); 116-127 ; Журнал инфектологии; Том 14, № 2 (2022); 116-127 ; 2072-6732 ; 10.22625/2072-6732-2022-14-2
Θεματικοί όροι: SARS-CoV-2, COVID-19 associated mucormycosis, mucormycosis, rhino-orbital mucormycosis, Rhizopus spp, риноцеребральный мукормикоз, COVID-19, COVID-19-ассоциированный мукормикоз
Περιγραφή αρχείου: application/pdf
Relation: https://journal.niidi.ru/jofin/article/view/1360/980; Frias-De-Leon MG, Pinto-Almazan R, Hernandez-Castro R, et al. Epidemiology of systemic mycoses in the COVID-19 pandemic. J Fungi (Basel). 2021;7(7):556.; Salmanton-Garcia J, Sprute R, Stemler J, et al. COVID-19-associated pulmonary Aspergillosis, March-August 2020. Emerg Infect Dis. 2021;27(4):1077-1086.; Koehler P, Cornely OA, Bottiger BW, et al. COVID-19 associated pulmonary aspergillosis. Mycoses. 2020;63(6):528-534.; Hoenigl M, Seidel D, Carvalho A, et al. The emergence of COVID-19 associated mucormycosis: Analysis of cases from 18 countries. The Lancet. 2021;Preprint: 33.; Rocha ICN, Hasan MM, Goyal S, et al. COVID-19 and mucormycosis syndemic: double health threat to a collapsing healthcare system in India. Trop Med Int Health. 2021;26(9):1016-1018.; Rudramurthy SM, Hoenigl M, Meis JF, et al. ECMM/ ISHAM recommendations for clinical management of COVID-19 associated mucormycosis in low- and middle-income countries. Mycoses. 2021;64(9):1028-1037; Salmanton-García J, Koehler P, Kindo A, Falces-Romero I, García-Rodríguez J, Ráčil Z, Chen SC, Klimko N, et al. Needles in a haystack: Extremely rare invasive fungal infections reported in FungiScopeⓇ -Global Registry for Emerging Fungal Infections. J Infect. 2020 Nov;81(5):802-815. doi:10.1016/j.jinf.2020.08.015. Epub 2020 Aug 13. PMID: 32798532.; Klimko N, Kozlova Y, Khostelidi S, Shadrivova O, Borzova Y, Burygina E, Vasilieva N, Denning DW. The burden of serious fungal diseases in Russia. Mycoses. 2015 Oct;58 Suppl 5:58-62. doi:10.1111/myc.12388. PMID: 26449508.; Sen, M., Honavar, S. G., Bansal, R., Sengupta, S., Rao, R., et al. Epidemiology, clinical profile, management, and outcome of COVID-19-associated rhino-orbital-cerebral mucormycosis in 2826 patients in India – Collaborative OPAI-IJO Study on Mucormycosis in COVID-19 (COSMIC), Report 1. Indian journal of ophthalmology, 69(7), 1670–1692. https://doi.org/10.4103/ijo.IJO_1565_21; Prakash H, Chakrabarti A. Epidemiology of Mucormycosis in India. Microorganisms. 2021;9(3):523. Published 2021 Mar 4. doi:10.3390/microorganisms9030523; Bellanger AP, Navellou JC, Lepiller Q, et al. Mixed mold infection with Aspergillus fumigatus and Rhizopus microsporus in a severe acute respiratory syndrome Coronavirus 2 (SARS-CoV-2) patient. Infect Dis now. 2021;51(7):633-635.; Seidel D, Simon M, Sprute R, et al. Results from a national survey on COVID-19-associated mucormycosis in Germany: 13 patients from six tertiary hospitals. Mycoses. 2021;00:1–7. https://doi.org/10.1111/myc.1337; Buil JB, van Zanten ARH, Bentvelsen RG, et al. Case series of four secondary mucormycosis infections in COVID-19 patients, the Netherlands. Euro Surveill. 2021;26(23):2100510.; Evert K, Dienemann T, Brochhausen C, et al. Autopsy findings after long-term treatment of COVID-19 patients with microbiological correlation. Virchows Arch. 2021;479(1):97-108.; Hanley B, Naresh KN, Roufosse C, et al. Histopathological findings and viral tropism in UK patients with severe fatal COVID-19: a postmortem study. Lancet Microbe. 2020;1(6):e245-e253.; Zurl C, Hoenigl M, Schulz E, et al. Autopsy proven pulmonary Mucormycosis due to Rhizopus microsporus in a critically Ill COVID-19 patient with underlying hematological malignancy. J Fungi (Basel). 2021;7(2):88. 17. Pasero D, Sanna S, Liperi C, et al. A challenging complication following SARS-CoV-2 infection: a case of pulmonary mucormycosis. Infection. 2020;49(5):1055-1060; Placik DA, Taylor WL, Wnuk NM. Bronchopleural fistula development in the setting of novel therapies for acute respiratory distress syndrome in SARS-CoV-2 pneumonia. Radiol Case Rep. 2020;15(11):2378–2381. doi:10.1016/j.radcr.2020.09.026. [PMC free article] [PubMed] [Cross-Ref] [Google Scholar]; Mehta S, Pandey A. Rhino-orbital mucormycosis associated with COVID-19. Cureus. 2020;12(9):e10726. [PMC free article] [PubMed] [Google Scholar]; Monte Junior ESD, Santos M, Ribeiro IB et al. Rare and fatal gastrointestinal mucormycosis (Zygomycosis) in a COVID-19 patient: a case report. Clin Endosc. 2020;53(6):746–749. doi:10.5946/ce.2020.180. [PMC free article] [PubMed] [Cross-Ref] [Google Scholar]; Pasero D, Sanna S, Liperi C, et al. challenging complication following SARS-CoV-2 infection: a case of pulmonary mucormycosis. Infection. 2020 Dec 17:1–6. doi:10.1007/s15010-020-01561-x. Epub ahead of print. PMID: 33331988; PMCID: PMC7745708.; Mekonnen ZK, Ashraf DC, Jankowski T, et al. Acute Invasive Rhino-Orbital Mucormycosis in a Patient With COVID-19-Associated Acute Respiratory Distress Syndrome. Ophthalmic Plast Reconstr Surg. 2020. doi:10.1097/IOP.0000000000001889. [PMC free article] [PubMed]; Zurl C, Hoenigl M, Schulz E, Hatzl S, Gorkiewicz G, Krause R, et al. Autopsy Proven Pulmonary Mucormycosis Due to Rhizopus microsporus in a Critically Ill COVID-19 Patient with Underlying Hematological Malignancy. J Fungi (Basel). 2021 Jan 27;7(2):88. doi:10.3390/jof7020088. PMID: 33513875; PMCID: PMC7912223.; Хостелиди, С.Н. Мукормикоз на фоне COVID-19: описание клинического случая и обзор литературы / С.Н. Хостелиди [и др.] // Клиническая микробиология и антимикробная химиотерапия. – 2021. – T. 23, № 3. – C. 255–262.; Donnelly J.P., Chen SC, Kauffman CA. at al. Revision and Update of the Consensus Definitions of Invasive Fungal Disease From the European Organization for Research and Treatment of Cancer and the Mycoses Study Group Education and Research Consortium. Clinical Infectious Diseases, Volume 71, Issue 6, 15 September 2020, p.1367–1376, https://doi.org/10.1093/cid/ciz1008; Временные методические рекомендации «Профилактика, диагностика и лечение новой коронавирусной инфекции (COVID-19)». Версия 10, 08.02.2021. https://static-0.minzdrav.gov.ru; Prakash H, Skiada A, Paul RA, Chakrabarti A, Rudramurthy SM. Connecting the Dots: Interplay of Pathogenic Mechanisms between COVID-19 Disease and Mucormycosis. J Fungi (Basel). 2021;7(8):616. Published 2021 Jul 29. doi:10.3390/jof7080616; Prakash H, Singh S, Rudramurthy S, Singh P, Mehta N, Shaw D, et al. An aero mycological analysis of mucormycetes in indoor and outdoor environments of Northern India. Med Mycol. 2020;58(1):118–23. https://doi.org/10.1093/Mmy/Myz031; Хостелиди, С.Н. Клинико-лабораторные особенности мукормикоза у взрослых / С.Н. Хостелиди [и др.] // Проблемы медицинской микологии. – 2020. – Т. 22, № 2. – C. 22–28.; Moorthy A, Gaikwad R, Krishna S, Hegde R, Tripathi KK, Kale PG, Rao PS, Haldipur D, Bonanthaya K. SARS-CoV-2, Uncontrolled Diabetes and Corticosteroids-An Unholy Trinity in Invasive Fungal Infections of the Maxillofacial Region? A Retrospective, Multi-centric Analysis. J Maxillofac Oral Surg. 2021 Mar 6:1-8. doi:10.1007/s12663-021-01532-1. Epub ahead of print. PMID: 33716414; PMCID: PMC7936599.; Sarkar S, Gokhale T, Choudhury SS, Deb AK. COVID-19 and orbital mucormycosis. Indian J Ophthalmol. 2021 Apr;69(4):1002-1004. doi:10.4103/ijo.IJO_3763_20. PMID: 33727483; PMCID: PMC8012924.; Kumar M, Sarma DK, Shubham S, et al. Mucormycosis in COVID-19 pandemic: Risk factors and linkages. Curr Res Microb Sci. 2021;2:100057. doi:10.1016/j.crmicr.2021.100057.; Cornely OA, Alastruey-Izquierdo A, Arenz D, et al. Global guideline for the diagnosis and management of mucormycosis: an initiative of the European Confederation of Medical Mycology in cooperation with the Mycoses Study Group Education and Research Consortium. Lancet Infect Dis. 2019;19(12):e405-e421. doi:10.1016/S1473-3099(19)30312-3.; https://journal.niidi.ru/jofin/article/view/1360
-
2